Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease. A nationwide series

Sandborn, 2001, Etanercept for active Crohn's disease: a randomized double blind, placebo-controlled trial, Gastroenterology, 121, 1088, 10.1053/gast.2001.28674 Fouache, 2009, Paradoxical adverse events of anti-tumour necrosis factor therapy for spondylarthropathies: a retrospective study, Rheumatology, 48, 761, 10.1093/rheumatology/kep083 Immediato-Daiën, 2009, Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases, Rheumatology, 48, 883, 10.1093/rheumatology/kep046 Montgommery, 2005, Colon inflammatory, 213 Oh, 2005, Development of Crohn's disease in a patient taking etanercept, J Rheumatol, 32, 752 Ahmad, 2007, Development of Crohn's disease in a patient on etanercept for psoriasis, Br J Dermatol, 157, 396, 10.1111/j.1365-2133.2007.08009.x Song, 2008, New onset of Crohn's disease during treatment of active ankylosing spondylitis with etanercept, J Rheumatol, 35, 532 Tsochatzis, 2007, First appearance of Crohn's disease following infliximab treatment for spondylarthropathy, Scand J Gastrenterol, 42, 784, 10.1080/00365520601106228 Yazisiz, 2008, Developemnt of Crohn's disease following anti-tumour necrosis factor therapy (etanercept), Colorectal Dis, 10, 953 Elkayam, 2008, The changing face of spondylarthropathies under TNF-α blockade, Open Rheumatol J, 2, 53, 10.2174/1874312900802010053 Haraoui, 2009, Emergence of Crohn's disease during treatment with the anti-tumor necrosis factor agent etanercept for ankylosing spondylitis: possible mechanisms of action, Semin Arthritis Rheum, 39, 176, 10.1016/j.semarthrit.2008.06.004 Ruemmele, 2004, Development of Crohn's disease during anti TNF-α therapy in a child with juvenile idiopathic arthritis, J Ped Gastroenterol Nutr, 39, 203, 10.1097/00005176-200408000-00016 Wiegering, 2010, Crohn's disease during etanercept therapy in juvenile idiopathic arthritis: a case report and review of the literature, Rheumatol Int, 30, 801, 10.1007/s00296-009-0991-7 Dallochio, 2010, Occurrence of inflammatory bowel disease during treatment of juvenile idiopathic arthritis with etanercept: a French retrospective study, Rheumatology, 49, 1694, 10.1093/rheumatology/keq136 Oikonomou, 2010, Emergence of Crohn's disease in juvenile idiopathic arthritis during treatment of etanercept: a causal link or a mere coincidence?, J Gastrointestin Liver Dis, 19, 342 Davis, 2003, Recombinant human tumor necrosis factor receptor (etanercept) fro treating ankylosing spondylitis. A randomized controlled trial, Arthritis Rheum, 48, 3230, 10.1002/art.11325 Brandt, 2005, Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis, Rheumatology, 44, 342, 10.1093/rheumatology/keh475 Prescott, 2007, Tumor necrosis factor alpha inhibitor associated ulcerative colitis, Am J Med Sci, 333, 137, 10.1097/MAJ.0b013e3180312362 Mielants, 1995, The evolution of spondylarthropathies in relation to gut histology. III. Relation between gut and joint, J Rheumatol, 22, 2279 Toussirot, 1997, Crohn's disease associated with seropositive rheumatoid arthritis, Clin Exp Rheumatol, 15, 307 Braun, 2007, Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor α agents, Arthritis Rheum, 57, 639, 10.1002/art.22669 Gerloni, 2008, Focus on adverse events of tumor necrosis factor a blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients, Ann Rheum Dis, 67, 1145, 10.1136/ard.2007.069484 Marzo Ortega, 2003, Efficacy of etanercept for the treatment of Crohn's related spondylarthritis but not colitis, Ann Rheum Dis, 62, 74, 10.1136/ard.62.1.74 Van den Brande, 2003, Infliximab but not etanercept induces apoptosis in lamina propria T lymphocytes from patients with Crohn's disease, Gastroenterology, 124, 1774, 10.1016/S0016-5085(03)00382-2 Zou, 2003, Up regulation of the production of tumour necrosis factor alpha and interferon gamma by T cells in ankylosing spondylitis. During treatment with etanercept, Ann Rheum Dis, 62, 561, 10.1136/ard.62.6.561